CTMC is a purpose-driven cell therapy accelerator that partners with innovative biotech companies to bring transformative cancer treatments to patients faster. By integrating deep manufacturing expertise with financial and strategic co-development support, CTMC helps programs efficiently progress from early-stage development through clinical proof of concept.
With a model centered around partnerships, platforms, and people, CTMC has enabled the successful filing of eight INDs in just three years. The company’s mission is to expand global access to cell therapies by building scalable manufacturing capabilities and empowering institutions—such as hospitals and cancer centers—to deliver these lifesaving treatments closer to patients.
Company Details
- Employees
- 112
- Founded
- -
- Address
- 2130 W Holcombe Blvd, Houston,texas 77030,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.ctmc.com
- Keywords
- cell therapy, biologics, therapeutics, cGMP manufacturing, clinical trials, academic cancer research, quality control + quality assurance, analytical development, CMC quality by design, IND, biotech, innovative development, capital investment.
- HQ
- Houston, Texas
Ctmc Questions
Ctmc's website is http://www.ctmc.com
Ctmc's LinkedIn profile is https://www.linkedin.com/company/celltherapymanufacturingcenter
Ctmc has
112 employees.
View email and phone details for 112
employees at Ctmc.
Ctmc's industry is
Biotechnology Research
Ctmc's top competitors are
Marker Therapeutics, Inc.,
Resilience,
Cellready™,
Cellipont Bioservices,
Biohouston,
Md Anderson Cancer Center,
Immatics,
Kiromic Biopharma, Inc.,
Neurogene Inc.,
Lonza.
Ctmc's categories are Biotechnology Research
Ctmc's founding year is 2022
